drugset / Trial / NCT00732368

A Long-term Study of Mometasone Furoate in Patients With Perennial Allergic Rhinitis (Study P04459)

NCT00732368

Phase 3 Completed 98 enrolled Organon and Co
NaSingle-groupOpen-labelTreatment

Summary

This study examined the safety and effectiveness of long-term administration of mometasone nasal spray in patients with perennial allergic rhinitis. Patients received mometasone for 12 weeks plus an additional 12 weeks if patient agreed to continue. Dose of mometasone could be decreased or increased during the study based on patient's response.

Timeline

Start
2005-05-01
Primary completion
2006-01-01
Completion
2006-01-01

Publications

  • Results T. Ishikawa et. al; Practica otologica. Suppl. 122 Page1-17(2008.11) -Japanese language journal

Drugs

EvaluationDrugModalityDoseRoute
Subject Mometasone furoate Other / unclassified 200 ug Intranasal